| Primary |
| Hypertension |
50.2% |
| Essential Hypertension |
6.9% |
| Diabetes Mellitus |
5.4% |
| Depression |
5.0% |
| Cardiac Failure Congestive |
3.1% |
| Oedema Peripheral |
3.1% |
| Benign Prostatic Hyperplasia |
2.7% |
| Cardiac Failure |
2.7% |
| Pain |
2.7% |
| Prophylaxis |
2.7% |
| Arrhythmia |
1.9% |
| Insomnia |
1.9% |
| Parkinson's Disease |
1.9% |
| Cough |
1.5% |
| Glaucoma |
1.5% |
| Hypertensive Heart Disease |
1.5% |
| Vertigo |
1.5% |
| Anxiety |
1.2% |
| Arthralgia |
1.2% |
| Atrial Fibrillation |
1.2% |
|
| Hyponatraemia |
20.0% |
| Hyperkalaemia |
7.8% |
| Renal Failure Chronic |
5.6% |
| Hypoglycaemia |
4.4% |
| Hypotension |
4.4% |
| Lung Disorder |
4.4% |
| Malaise |
4.4% |
| Rhabdomyolysis |
4.4% |
| Syncope |
4.4% |
| Vertigo |
4.4% |
| Vision Blurred |
4.4% |
| Weight Decreased |
4.4% |
| Fall |
3.3% |
| Liver Injury |
3.3% |
| Orthostatic Hypertension |
3.3% |
| Presyncope |
3.3% |
| Renal Failure |
3.3% |
| Renal Failure Acute |
3.3% |
| Somnolence |
3.3% |
| Subarachnoid Haemorrhage |
3.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.3% |
| Hypertension |
23.7% |
| Product Used For Unknown Indication |
6.4% |
| Hypertensive Heart Disease |
5.1% |
| Benign Prostatic Hyperplasia |
4.3% |
| Diabetes Mellitus |
3.3% |
| Cardiac Failure |
3.1% |
| Cardiac Failure Congestive |
3.1% |
| Insomnia |
3.1% |
| Myocardial Ischaemia |
3.1% |
| Pain |
2.5% |
| Essential Hypertension |
2.0% |
| Bronchitis |
1.5% |
| Extrasystoles |
1.5% |
| Oedema |
1.5% |
| Polyneuropathy |
1.5% |
| Renal Impairment |
1.5% |
| Rhinitis Allergic |
1.5% |
| Bursitis |
1.0% |
| Coronary Artery Disease |
1.0% |
|
| Vomiting |
16.5% |
| Renal Failure Chronic |
11.0% |
| Hyponatraemia |
9.9% |
| Renal Failure |
7.7% |
| Hyperkalaemia |
5.5% |
| Syncope |
5.5% |
| Lung Disorder |
4.4% |
| Subarachnoid Haemorrhage |
4.4% |
| Drug Exposure During Pregnancy |
3.3% |
| Intra-uterine Death |
3.3% |
| Liver Injury |
3.3% |
| Presyncope |
3.3% |
| Somnolence |
3.3% |
| Sopor |
3.3% |
| Therapeutic Agent Toxicity |
3.3% |
| Vision Blurred |
3.3% |
| Blood Pressure Increased |
2.2% |
| Bradycardia |
2.2% |
| Eczema |
2.2% |
| Parkinson's Disease |
2.2% |
|
| Concomitant |
| Hypertension |
25.7% |
| Drug Use For Unknown Indication |
15.2% |
| Product Used For Unknown Indication |
12.5% |
| Rheumatoid Arthritis |
11.4% |
| Diabetes Mellitus |
4.0% |
| Breast Cancer |
3.7% |
| Pain |
3.3% |
| Depression |
3.1% |
| Osteoporosis |
2.9% |
| Prophylaxis |
2.4% |
| Diffuse Large B-cell Lymphoma |
2.2% |
| Atrial Fibrillation |
2.0% |
| Hypercholesterolaemia |
2.0% |
| Hepatitis C |
1.6% |
| Asthma |
1.5% |
| Hypothyroidism |
1.5% |
| Bronchitis |
1.3% |
| Diuretic Therapy |
1.3% |
| Blood Cholesterol Increased |
1.2% |
| Hiv Infection |
1.2% |
|
| Vomiting |
17.4% |
| Weight Decreased |
8.0% |
| Weight Increased |
7.5% |
| Somnolence |
6.0% |
| Oedema Peripheral |
5.0% |
| Urticaria |
5.0% |
| Neutropenia |
4.5% |
| Vertigo |
4.5% |
| Rash |
4.0% |
| Renal Failure Acute |
4.0% |
| Spinal Osteoarthritis |
4.0% |
| Thrombocytopenia |
4.0% |
| Erectile Dysfunction |
3.5% |
| Hypokalaemia |
3.5% |
| Pneumonia |
3.5% |
| Renal Failure |
3.5% |
| Sputum Culture Positive |
3.5% |
| Hypersensitivity |
3.0% |
| Loss Of Consciousness |
3.0% |
| Myocardial Infarction |
3.0% |
|
| Interacting |
| Hypertension |
38.1% |
| Drug Use For Unknown Indication |
19.0% |
| Atrial Fibrillation |
9.5% |
| Extrasystoles |
9.5% |
| Prostate Cancer |
9.5% |
| Schizophreniform Disorder |
9.5% |
| Essential Hypertension |
4.8% |
|
| Somnolence |
37.5% |
| Presyncope |
25.0% |
| Drug Interaction |
12.5% |
| Hyperkalaemia |
12.5% |
| Vomiting |
12.5% |
|
